Sunday, June 3, 2012

Google Alert - pharmaceutical news

News7 new results for pharmaceutical news
 
Is Sun Pharma getting back on the acquisition track?
Livemint
At first sight, Sun Pharmaceutical Industries Ltd's sales guidance for 2012-13 appears conservative compared with its performance last fiscal. The company's sales in 2011-12 grew by 40% to Rs8,006 crore, and it expects sales to grow by 18-20%.
See all stories on this topic »
Pharma sector likely to grow at 15.3% CAGR
Hindu Business Line
PTI Growth rate for the Indian pharmaceutical market is set to rise over medium-term, according to a research report. The CAGR (compound annual growth rate) over the past three years had been 12.4 per cent, but it is expected to be up at 15.3 per cent ...
See all stories on this topic »
Pharmaceutical gifts Bauchi diabetics N2m drugs
BusinessDay
Ltd, a pharmaceutical company, on Saturday, distributed N2 million worth of drugs free of charge to people suffering from diabetes in Bauchi. Paul Midala, the company's representative, said the drugs comprised methylcobalamin, metformin hydrochloride, ...
See all stories on this topic »

BusinessDay
£30bn bill to purify water system after toxic impact of contraceptive pill
The Guardian
Water and pharmaceutical companies dispute the science involved and argue the costs are prohibitive. By contrast, many environmental researchers say the proposal is sound. Ethinyl estradiol (EE2), the main active ingredient of contraceptive pills, ...
See all stories on this topic »

The Guardian
ASCO Presentations Highlight Preliminary Results of Studies with MLN9708 ...
MarketWatch (press release)
CAMBRIDGE, Mass., Jun 03, 2012 (BUSINESS WIRE) -- Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported phase 1 and phase 1/2 preliminary results from three studies evaluating the safety, ...
See all stories on this topic »
Teva's Treanda Delays Tumor Growth
Bloomberg
Teva Pharmaceutical Industries Ltd. (TEVA)'s Treanda worked better than a standard therapy and with fewer side effects to slow the growth of immune system tumors, a finding that could push more doctors to prescribe the drug as an initial treatment.
See all stories on this topic »
In Euro Zone, The Coming Crisis of People's Health
Forbes
The pharmaceutical giant Roche has decided to set a ceiling on the orders that 11 Spanish hospitals will be allowed to place until they settle at least part of their ballooning unpaid bills. One more center, the Hospital Provincial de Castellón, ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost